Trials / Conditions / Neovascular Macular Degeneration
Neovascular Macular Degeneration
4 registered clinical trials studyying Neovascular Macular Degeneration.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration NCT02204683 | University of Nebraska | Phase 1 |
| Completed | Aflibercept in Polypoidal Choroidal Vasculopathy NCT02120950 | Bayer | Phase 4 |
| Completed | Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments NCT00590694 | Pacific Eye Associates | Phase 2 / Phase 3 |
| Completed | Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration NCT01245387 | Pfizer | — |